BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  MannKind Corporation to Hold 2022 Second Quarter Financial Results Conference Call on August 9, 2022

  MannKind Corporation will release its 2022 second quarter and year to date financial results and its management will host a conference call to discuss these results and corporate updates at 5:00 PM on Tuesday, August 9, 2022.

  August 2, 2022

   · 

  1 min read
• DermaPrecise(TM) Injection System Shown to Produce Consistently High Cell Count and Viability for Cell Therapy Injections

  RepliCel Life Sciences Inc., a company developing next-generation technologies in aesthetics and orthopedics, announced it has received test results showing that cells injected through the DermaPrecise™ Injector maintained >99% viability.

  August 2, 2022

   · 

  8 min read
• Drug Development

  Axcella Announces Highly Promising Results from Phase 2a Placebo Controlled Clinical Trial for Long COVID

  Axcella Therapeutics reported topline results from the Phase 2a randomized, double-blind, placebo-controlled investigation to evaluate the efficacy and safety of AXA1125 in patients with fatigue related to Long COVID.

  August 2, 2022

   · 

  10 min read
• Biotech Beach

  Phanes Therapeutics’ anti-CD47 antibody patent granted in the US

  Phanes Therapeutics, Inc. (Phanes), an emerging leader in innovative discovery research and clinical development in oncology, announced today that the U.S. Patent and Trademark Office (USPTO) has granted the patent (Patent No. US 11,401,329) of its anti-CD47 antibodies.

  August 2, 2022

   · 

  2 min read
• Business

  Astellas Announces Management Structure - Aug 02, 2022

  Astellas Pharma Inc. announced the following changes to its management structure effective October 1, 2022.

  August 2, 2022

   · 

  6 min read
• Hospital Capacity Management Solutions Market, 2031 | Trends and Opportunities | Drivers and Restraints | Regional Analysis

  The drive for hospital capacity management solutions mainly stemmed from the potential need for better hospital capacity planning methods and strategies, world over.

  August 2, 2022

   · 

  7 min read
• Viral Vectors Manufacturing Market: Increase in the Number of Gene Therapy Candidates due to Rapid Development of Diseases to Drive the Market

  Wilmington, Delaware, United States, Transparency Market Research Inc.: Gene therapy is one of the best treatment options for most chronic diseases.

  August 2, 2022

   · 

  5 min read